Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer
Sign Up to like & getrecommendations! Published in 2017 at "Science Signaling"
DOI: 10.1126/scisignal.aal2328
Abstract: Targeting TNF receptor type 2 may be a new avenue for treating ovarian cancer (Torrey et al., in 17 January 2017 issue). Tumor necrosis factor receptor 2 (TNFR2) is expressed both by some cancer cells… read more here.
Keywords: immune checkpoint; targeting tnfr2; tnfr2; tnfr2 immune ... See more keywords